Composition containing roselle and preparation method thereof

By combining hibiscus extract with cocoa extract, coating protein, and fermentation complex, the problem of low bioavailability of plant extracts was solved, achieving a highly effective blood lipid-lowering effect, improving the intestinal flora structure, and inhibiting lipase activity.

CN121421178APending Publication Date: 2026-01-30CHANGSHA WORLD-WAY BIOTECH INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511711777.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-11-20
Publication Date
2026-01-30

AI Technical Summary

Technical Problem

Existing plant extract compositions have low bioavailability, low efficacy, and lack synergistic or antagonistic effects between components.

Method used

The combination of hibiscus extract with cocoa extract, coating protein, fermentation complex and excipients is used. Through multi-step pretreatment and compound solvent extraction, polarity is adjusted to improve bioavailability. The fermentation complex produces active ingredients such as urolithin A, puerarin peptide and perillol, which synergistically lower blood lipids.

Benefits of technology

It improves the extraction rate and stability of active ingredients, promotes anthocyanin absorption, improves intestinal flora structure, inhibits lipase activity, and synergistically lowers blood lipids, thus having the effects of suppressing appetite and promoting fat decomposition.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
Patent Text Reader

Abstract

The invention relates to the technical field of health-care products, and particularly discloses a roselle-containing composition and a preparation method thereof, and the roselle-containing composition comprises the following components: a roselle extract, a cocoa extract, coating protein, a fermentation compound and auxiliary materials; the added roselle extract is subjected to multi-step pretreatment, the extraction rate and stability of active ingredients are improved, and the polarity of the roselle extract can be adjusted by adopting a composite solvent for extraction, so that the bioavailability is improved; the added cocoa extract can reduce oxidation of anthocyanin, and the cocoa extract and the roselle extract are synergistically used for reducing blood fat by inhibiting lipase activity and adjusting cholesterol; the fermentation compound can generate urolithin A, pueraria peptide and perillyl alcohol to further assist in reducing blood fat, and the coating protein improves the stability and absorption efficiency of the roselle extract; the auxiliary materials can improve the bioavailability of the active components of the raw materials, and the prepared composition has the effects of inhibiting appetite, promoting lipolysis, inhibiting fat absorption and reducing blood fat through synergistic effects of all the components.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of health product technology, specifically to a composition containing roselle and its preparation method. Background Technology

[0002] The incidence of metabolic diseases such as obesity and hyperlipidemia is increasing year by year. Currently, intervention methods for weight and blood lipids are mainly divided into two categories: chemical drugs and traditional dietary therapy. Although chemical drugs (such as lipase inhibitors and appetite suppressants) can take effect quickly, long-term use can easily cause side effects such as gastrointestinal discomfort and liver and kidney damage, and rebound is likely after discontinuation, thus limiting their clinical application. Traditional dietary therapy (such as dietary fiber supplementation and low-calorie meal replacements) have problems such as slow onset of action, monotonous taste, and poor compliance, making it difficult to meet the public's demand for both "high efficiency" and "safety". Plant extracts have complex and natural component systems. Lipid-lowering active ingredients (such as flavonoids, saponins, and organic acids) often coexist with impurities (such as polysaccharides, tannins, and pigments). Active ingredients in plant extracts (such as fat-soluble saponins and macromolecular polysaccharides) often suffer from poor solubility, weak gastrointestinal stability, and low absorption efficiency. This results in most active ingredients being degraded or excreted before reaching lipid metabolism-related tissues (such as the liver and intestines), leading to generally low bioavailability. Currently, most compositions only achieve the "addition of single-component effects," lacking synergistic or antagonistic effects between components. Therefore, a composition that can be extracted from natural ingredients and effectively lower blood lipids is needed to solve these technical problems. Summary of the Invention

[0003] The technical problem to be solved by the present invention is to provide a composition containing roselle and a method for preparing the same, so as to solve the problems of low bioavailability and low efficacy of plant extract compositions in the prior art.

[0004] The present invention solves the above-mentioned technical problems. The present invention provides a composition containing hibiscus, comprising the following components in parts by weight: 19-22 parts of hibiscus extract, 3-5 parts of cocoa extract, 25-35 parts of coating protein, 3-7 parts of fermentation complex, and 5-9 parts of excipients. The preparation of the roselle extract includes the following steps: Step 1: After removing the stems from the roselle calyxes, vacuum dry them to a moisture content of 6%-8%, grind them into powder, add 0.1-0.3% EDTA-2Na solution at a solid-liquid ratio of 1:12-16 (g / mL), stir well, soak in a constant temperature water bath at 40-45℃ for 1 hour, and then treat with low temperature plasma and dry under reduced pressure to obtain pretreated calyx powder. Step 2: Add an ethanol-ethyl acetate-fatty acid composite solvent to the pretreated calyx powder at a material-liquid ratio of 1:12-15 (g / mL), and simultaneously add glyceryl monostearate at a volume fraction of 1%-3% of the composite solvent. Perform ultrasonic extraction at an ultrasonic frequency of 20-30kHz for 80-90 minutes, then separate and purify with macroporous resin, followed by vacuum compression drying. EDTA-2Na chelation and plasma inactivation of residual polyphenylene ether in the calyx prevent the formation of insoluble chelates and oxidative degradation of active ingredients in the calyx. Plasma etching creates micropores in the calyx cell walls, increasing permeability channels. The composite solvent serves as the base solvent for anthocyanins and organic acids, while ethyl acetate provides a weakly hydrophobic environment. Fatty acids undergo esterification with the hydroxyl groups of anthocyanins, enhancing lipophilicity and improving the lipophilicity and compatibility of the active ingredients. The composite solvent is an ethanol-ethyl acetate-fatty acid composite solvent with a volume ratio of 1-3:1:1-3; The plasma has a power of 100-150W, a duration of 20-30s, and a vacuum degree of 40-50Pa. The coating protein is obtained by mixing zein and glycine in a mass ratio of 7-9:1-3, followed by homogenization and emulsification. The homogenization emulsification is carried out at a pressure of 30-40 MPa and a temperature of 40-45℃. The fermentation complex is prepared by washing and mixing kudzu root, raspberry, and perilla in a mass ratio of 5-7:1-3:2, sterilizing under high pressure, adding water at a solid-liquid ratio of 1:5 (g / mL), adding compound bacteria, fermenting at 30-35℃ for 8-12 hours, with an inoculation amount of 3%-5% of the total dry weight of the fermentation raw materials, cooling after sterilization, and then drying under reduced pressure. The compound bacteria consist of acetic acid bacteria, brewer's yeast and lactobacillus plantarum in a mass ratio of 1:1-3:1-3; The excipients consist of oat β-glucan, fish oil, and chitosan in a mass ratio of 5:1 to 3:1. Oat β-glucan can buffer pH value and prevent anthocyanin degradation caused by the alkalinity of chitosan, while fish oil improves the fat-soluble absorption of anthocyanins. The present invention also provides a method for preparing a composition containing hibiscus, comprising the following steps: Step 1: Mix hibiscus extract, cocoa extract and coated protein at 30-40℃ to obtain mixture A; Step 2: Homogenize the excipients at 30-40℃ for 20-30 minutes, then mix them with the fermentation complex for 10-20 minutes to obtain mixture B; Step 3: Mix mixture A and mixture B together and dry to obtain a composition containing roselle.

[0005] The beneficial effects of this invention are as follows: This invention provides a composition containing hibiscus. The added hibiscus extract undergoes multi-step pretreatment to improve the extraction rate and stability of active ingredients. The use of compound solvent extraction can regulate the polarity of the hibiscus extract, thereby improving its bioavailability. The added cocoa extract contains natural phospholipids and other components that can promote the absorption of anthocyanins in the hibiscus extract and reduce anthocyanin oxidation. The two promote each other's absorption. At the same time, the cocoa polyphenols contained in it and the hibiscus extract can improve the intestinal flora structure and indirectly assist in lowering blood lipids. It can also synergistically lower blood lipids by inhibiting lipase activity and regulating cholesterol. The fermentation complex can produce urolithin A, puerarin peptide and perillol, which can further assist in lowering blood lipids. The coating protein improves the stability and absorption efficiency of the hibiscus extract. The excipients can improve the bioavailability of active ingredients such as hibiscus and fermentation complex. The resulting composition has the effects of suppressing appetite, promoting fat decomposition, inhibiting fat absorption and lowering blood lipids through the synergistic effect of each component. Detailed Implementation

[0006] The present invention will be further described in detail below through specific implementation examples. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of protection of the present invention. After reading the present invention, any modifications of the present invention in various equivalent forms by those skilled in the art fall within the scope of the appended claims.

[0007] Unless otherwise specified, all raw materials and reagents used in this invention are from the conventional market.

[0008] Example 1 A method for preparing a hibiscus-containing composition includes the following steps: Step 1: Mix 21 parts hibiscus extract, 4 parts cocoa extract and 30 parts coated protein at 35°C to obtain mixture A; The preparation of the roselle extract is as follows: Roselle calyxes are destalked and vacuum dried to a moisture content of 7%, ground into powder, and then mixed with 0.2% EDTA-2Na solution at a solid-liquid ratio of 1:14 (g / mL). The mixture is stirred evenly and soaked in a 40℃ constant temperature water bath for 1 hour. After low-temperature plasma treatment, the powder is dried under reduced pressure to obtain pretreated calyx powder. The plasma power is 130W, the time is 25s, and the vacuum degree is 45Pa. At a material-liquid ratio of 1:14 (g / mL), an ethanol-ethyl acetate-fatty acid composite solvent with a volume ratio of 2:1:2 is added to the pretreated calyx powder. At the same time, glyceryl monostearate with a volume fraction of 2% of the composite solvent is added. The mixture is ultrasonically extracted at an ultrasonic frequency of 25kHz for 85 minutes, separated and purified with macroporous resin, concentrated under reduced pressure, and dried to obtain the final product. The coating protein is obtained by mixing zein and glycine in a mass ratio of 8:2 and then homogenizing and emulsifying it. The homogenization emulsification was carried out at a pressure of 35 MPa and a temperature of 4 °C. Step 2: Homogenize 7 parts of excipients at 35℃ for 25 minutes, and then mix them with 5 parts of fermentation complex for 15 minutes to obtain mixture B; The fermentation complex is prepared by washing and mixing kudzu root, raspberry, and perilla in a mass ratio of 6:2:2, sterilizing under high pressure, adding water at a solid-liquid ratio of 1:5 (g / mL) to make a slurry, adding compound bacteria, fermenting at 30℃ for 10 hours, and inoculating at 4% of the total dry weight of the fermentation raw materials. After sterilization, the mixture is cooled and dried under reduced pressure. The compound bacteria consist of acetic acid bacteria, brewer's yeast and Lactobacillus plantarum in a mass ratio of 1:2:2; The excipients consist of oat β-glucan, fish oil, and chitosan in a mass ratio of 5:2:1. Step 3: Mix mixture A and mixture B together and dry to obtain a composition containing roselle.

[0009] Example 2 A method for preparing a hibiscus-containing composition includes the following steps: Step 1: Mix 19 parts hibiscus extract, 3 parts cocoa extract and 25 parts coated protein at 30°C to obtain mixture A; The preparation of the roselle extract is as follows: Roselle calyxes are destalked and vacuum dried to a moisture content of 6%, ground into powder, and then mixed with 0.1% EDTA-2Na solution at a solid-liquid ratio of 1:12 (g / mL). The mixture is then soaked in a 40℃ constant temperature water bath for 1 hour, and then treated with low-temperature plasma and dried under reduced pressure to obtain pretreated calyx powder. The plasma power is 100W, the time is 20s, and the vacuum degree is 40Pa. At a material-liquid ratio of 1:12 (g / mL), an ethanol-ethyl acetate-fatty acid composite solvent with a volume ratio of 1:1:1 is added to the pretreated calyx powder, and glyceryl monostearate with a volume fraction of 1% of the composite solvent is added. The mixture is ultrasonically extracted at an ultrasonic frequency of 20kHz for 80 minutes, separated and purified with macroporous resin, concentrated under reduced pressure, and dried to obtain the final product. The coating protein is obtained by mixing zein and glycine in a mass ratio of 7:1 and then homogenizing and emulsifying it. The homogenization emulsification was carried out at a pressure of 30 MPa and a temperature of 40 °C. Step 2: Homogenize 5 portions of excipients at 30°C for 20 minutes, then mix with 3 portions of fermentation complex for 10 minutes to obtain mixture B; The fermentation complex is prepared by washing and mixing kudzu root, raspberry, and perilla in a mass ratio of 5:1:2, sterilizing under high pressure, adding water at a solid-liquid ratio of 1:5 (g / mL) to make a slurry, adding compound bacteria, fermenting at 30℃ for 8 hours, and inoculating at 3% of the total dry weight of the fermentation raw materials. After sterilization, the mixture is cooled and dried under reduced pressure. The compound bacteria consist of acetic acid bacteria, brewer's yeast and Lactobacillus plantarum in a mass ratio of 1:1:1. The excipients consist of oat β-glucan, fish oil, and chitosan in a mass ratio of 5:1:1. Step 3: Mix mixture A and mixture B together and dry to obtain a composition containing roselle.

[0010] Example 3 A method for preparing a hibiscus-containing composition includes the following steps: Step 1: Mix 22 parts of hibiscus extract, 5 parts of cocoa extract and 35 parts of coated protein at 40°C to obtain mixture A; The preparation of the roselle extract is as follows: Roselle calyxes are destalked and vacuum dried to a moisture content of 8%, ground into powder, and then mixed with 0.3% EDTA-2Na solution at a solid-liquid ratio of 1:16 (g / mL). The mixture is then soaked in a 45℃ constant temperature water bath for 1 hour, and then treated with low-temperature plasma and dried under reduced pressure to obtain pretreated calyx powder. The plasma power is 150W, the time is 30s, and the vacuum degree is 50Pa. At a material-liquid ratio of 1:15 (g / mL), an ethanol-ethyl acetate-fatty acid composite solvent with a volume ratio of 3:1:3 is added to the pretreated calyx powder, and glyceryl monostearate with a volume fraction of 3% of the composite solvent is added. The mixture is ultrasonically extracted at an ultrasonic frequency of 30kHz for 90 minutes, separated and purified with macroporous resin, concentrated under reduced pressure, and dried to obtain the final product. The coating protein is obtained by mixing zein and glycine in a mass ratio of 9:3 and then homogenizing and emulsifying it. The homogenization emulsification was carried out at a pressure of 40 MPa and a temperature of 45 °C. Step 2: Homogenize 9 parts of excipients at 40℃ for 30 min, and then mix them with 7 parts of fermentation complex for 20 min to obtain mixture B; The fermentation complex is prepared by washing and mixing kudzu root, raspberry, and perilla in a mass ratio of 7:3:2, sterilizing under high pressure, adding water at a solid-liquid ratio of 1:5 (g / mL) to make a slurry, adding compound bacteria, fermenting at 35℃ for 12 hours, and inoculating at 5% of the total dry weight of the fermentation raw materials. After sterilization, the mixture is cooled and dried under reduced pressure. The compound bacteria consist of acetic acid bacteria, brewer's yeast and Lactobacillus plantarum in a mass ratio of 1:3:3. The excipients consist of oat β-glucan, fish oil, and chitosan in a mass ratio of 5:3:1. Step 3: Mix mixture A and mixture B together and dry to obtain a composition containing roselle.

[0011] Example 4 A method for preparing a hibiscus-containing composition includes the following steps: Step 1: Mix 20 parts hibiscus extract, 3 parts cocoa extract and 28 parts coated protein at 35°C to obtain mixture A; The preparation of the roselle extract is as follows: Roselle calyxes are destalked and vacuum dried to a moisture content of 7%, ground into powder, and then mixed with 0.1% EDTA-2Na solution at a solid-liquid ratio of 1:13 (g / mL). The mixture is then soaked in a 40℃ constant temperature water bath for 1 hour, and then treated with low-temperature plasma and dried under reduced pressure to obtain pretreated calyx powder. The plasma power is 150W, the time is 20s, and the vacuum degree is 40Pa. At a material-liquid ratio of 1:15 (g / mL), an ethanol-ethyl acetate-fatty acid composite solvent with a volume ratio of 1:1:3 is added to the pretreated calyx powder, and glyceryl monostearate at a volume fraction of 3% of the composite solvent is added. The mixture is then ultrasonically extracted at a frequency of 30kHz for 80 minutes, separated and purified with macroporous resin, concentrated under reduced pressure, and dried to obtain the final product. The coating protein is obtained by mixing zein and glycine in a mass ratio of 7:2 and then homogenizing and emulsifying it. The homogenization emulsification was carried out at a pressure of 30 MPa and a temperature of 45 °C. Step 2: Homogenize 6 portions of excipients at 30°C for 30 minutes, then mix with 4 portions of fermentation complex for 20 minutes to obtain mixture B; The fermentation complex is prepared by washing and mixing kudzu root, raspberry, and perilla in a mass ratio of 6:3:2, sterilizing under high pressure, adding water at a solid-liquid ratio of 1:5 (g / mL) to make a slurry, adding compound bacteria, fermenting at 35℃ for 8 hours, and inoculating at 5% of the total dry weight of the fermentation raw materials. After sterilization, the mixture is cooled and dried under reduced pressure. The compound bacteria consist of acetic acid bacteria, brewer's yeast and Lactobacillus plantarum in a mass ratio of 1:1:3. The excipients consist of oat β-glucan, fish oil, and chitosan in a mass ratio of 5:1:1. Step 3: Mix mixture A and mixture B together and dry to obtain a composition containing roselle.

[0012] Example 5 A method for preparing a hibiscus-containing composition includes the following steps: Step 1: Mix 21 parts hibiscus extract, 5 parts cocoa extract and 33 parts coated protein at 40°C to obtain mixture A; The preparation of the roselle extract is as follows: Roselle calyxes are destalked and vacuum dried to a moisture content of 7%, ground into powder, and then mixed with 0.3% EDTA-2Na solution at a solid-liquid ratio of 1:15 (g / mL). The mixture is then soaked in a 45℃ constant temperature water bath for 1 hour, and then treated with low-temperature plasma and dried under reduced pressure to obtain pretreated calyx powder. The plasma power is 100W, the time is 20s, and the vacuum degree is 40Pa. At a material-liquid ratio of 1:15 (g / mL), an ethanol-ethyl acetate-fatty acid composite solvent with a volume ratio of 3:1:2 is added to the pretreated calyx powder, and glyceryl monostearate with a volume fraction of 1% of the composite solvent is added. The mixture is ultrasonically extracted at an ultrasonic frequency of 20kHz for 90 minutes, separated and purified with macroporous resin, concentrated under reduced pressure, and dried to obtain the final product. The coating protein is obtained by mixing zein and glycine in a mass ratio of 8:3 and then homogenizing and emulsifying it. The homogenization emulsification was carried out at a pressure of 30 MPa and a temperature of 45 °C. Step 2: Homogenize 6 portions of excipients at 30°C for 30 minutes, then mix with 4 portions of fermentation complex for 20 minutes to obtain mixture B; The fermentation complex is prepared by washing and mixing kudzu root, raspberry, and perilla in a mass ratio of 6:2:2, sterilizing under high pressure, adding water at a solid-liquid ratio of 1:5 (g / mL) to make a slurry, adding compound bacteria, fermenting at 35℃ for 8 hours, and inoculating at 5% of the total dry weight of the fermentation raw materials. After sterilization, the mixture is cooled and dried under reduced pressure. The compound bacteria consist of acetic acid bacteria, brewer's yeast, and Lactobacillus plantarum in a mass ratio of 1:3:2. The excipients consist of oat β-glucan, fish oil, and chitosan in a mass ratio of 5:2:1. Step 3: Mix mixture A and mixture B together and dry to obtain a composition containing roselle.

[0013] Comparative Example 1 The difference between Comparative Example 1 and Example 1 is that Comparative Example 1 uses commercially available roselle extract instead of the roselle extract prepared in this invention, while other aspects remain unchanged.

[0014] Comparative Example 2 The difference between Comparative Example 2 and Example 1 is that the fermentation complex of Comparative Example 2 does not contain perilla, while everything else remains the same.

[0015] Comparative Example 3 The difference between Comparative Example 3 and Example 1 is that the complex bacteria in the fermentation complex of Comparative Example 3 does not contain acetic acid bacteria, while everything else remains the same.

[0016] Comparative Example 4 The difference between Comparative Example 4 and Example 1 is that the coating protein in Comparative Example 4 does not contain glycine, while all other aspects remain the same.

[0017] Comparative Example 5 The difference between Comparative Example 5 and Example 1 is that Comparative Example 5 does not contain oat β-glucan as an excipient, while the rest remains the same.

[0018] Comparative Example 6 The difference between Comparative Example 6 and Example 1 is that Comparative Example 6 does not contain cocoa extract, while everything else remains the same.

[0019] I. Detection of Lipase Inhibitory Activity Sample group: Contains hibiscus composition (ground into powder and dissolved in dimethyl sulfoxide to a mass concentration of 4 mg / mL); Positive control group: Orlistat (lipase inhibitor, 10 μmol / L); Blank control group: DMSO + Tris-HCl buffer + substrate (without lipase); Model blank group: DMSO + Tris-HCl buffer + lipase + substrate (no sample added); Reagents: PANC-1 lipase (Sigma), 4-methylumbelliferyl octanoate (4-MU-Octanoate, substrate), Tris-HCl buffer (pH 7.5).

[0020] Experimental steps Reaction system construction: Add 50 μL of sample (or positive control / blank control) and 50 μL of lipase solution (0.1 U / mL) to a 96-well plate and incubate at 37°C for 10 min (to allow the sample and enzyme to fully combine). Substrate reaction: Add 50 μL of substrate solution (100 μmol / L) and react at 37°C in the dark for 30 min; Detection: Fluorescence intensity was detected using an ELISA reader (excitation wavelength 360nm, emission wavelength 460nm), and the lipase inhibition rate was calculated.

[0021] Lipase inhibition rate (%) = [1 - (sample group fluorescence value - sample blank value) / (model group fluorescence value - model blank value)] × 100%; Each experiment was performed in parallel three times, and the results are the mean ± standard deviation. The experimental results are shown in Table 1.

[0022] Table 1. Inhibition rate of lipase As shown in Table 1, when the concentration of the roselle-containing composition of the present invention is 4 mg / mL, the lipase inhibition rate is ≥60%, which is close to that of the positive control group. The example group is significantly better than the comparative group, indicating that the composition prepared by the present invention can effectively reduce fat absorption.

[0023] II. Animals: SPF-grade SD rats (male, 6 weeks old, weighing 180-220g, 10 rats per group); High-fat diet: basic feed + 10% lard + 1.2% cholesterol + 0.2% sodium cholate (to construct a high-fat model); The blank control group consisted of individuals who were not given a high-fat diet plus an equal volume of saline without establishing a high-fat model. Sample group: composition 200 mg / kg / d (suspended in physiological saline). Positive control group: Atorvastatin (10 mg / kg / day, a commonly used lipid-lowering drug in clinical practice); Test kits: Serum total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) kit (enzymatic method), liver and kidney function kit (alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), serum creatinine (Cr), and safety of the test). The experimental results are shown in Table 2.

[0024] Table 2. Blood lipids and liver and kidney function in rats Table 2 shows that TC, TG, and LDL-C in the hyperlipidemia model group were significantly higher than those in the blank control (P<0.05), while HDL-C was significantly lower than that in the blank control (P<0.05), proving the successful establishment of the hyperlipidemia rat model. The experimental results from the examples and comparative groups show that hibiscus extract is the source of the core active substances and works synergistically with cocoa extract to lower blood lipids. Cocoa extract has a significant effect on reducing LDL-C and increasing HDL-C. The coating protein added in this invention reduces the loss of active ingredients and improves intestinal absorption. The fermentation raw materials and fermentation method provided in this invention produce a variety of effective lipid-lowering active ingredients. The raw materials of this invention have a synergistic effect, improving the lipid-lowering performance of the composition, and causing minimal damage to the liver and kidneys.

[0025] The embodiments described above are merely illustrative of several implementations of the present invention, and while the descriptions are specific and detailed, they should not be construed as limiting the scope of the present invention. It should be noted that those skilled in the art can make various modifications and improvements without departing from the concept of the present invention, and these modifications and improvements all fall within the scope of protection of the present invention. Therefore, the scope of protection of this patent should be determined by the appended claims.

Claims

1. A composition comprising Roselle, characterized in that, The composition comprises the following components by mass fraction: rose bayberry extract 19-22 parts, cocoa extract 3-5 parts, coating protein 25-35 parts, fermentation complex 3-7 parts, and auxiliary material 5-9 parts.

2. A composition comprising Roselle as claimed in claim 1, wherein, The preparation of the rose bayberry extract comprises the following steps: Step 1: after the rose bayberry calyx is stripped, vacuum drying is performed until the water content is 6%-8%, grinding into powder, then adding 0.1%-0.3% EDTA-2Na solution in a solid-liquid ratio of 1:12-16 (g / mL) to stir uniformly, soaking in a 40-45℃ constant temperature water bath for 1h, and low temperature plasma treatment, and then reducing pressure drying to obtain the pretreated calyx powder; Step 2: adding ethanol-ethyl acetate-fatty acid complex solvent to the pretreated calyx powder in a solid-liquid ratio of 1:12-15 (g / mL), while adding 1%-3% glyceryl monostearate in terms of volume fraction of the complex solvent, and then ultrasonic extraction is performed at an ultrasonic frequency of 20-30 kHz for 80-90 min, and then macroporous resin separation and purification are performed, and then reducing pressure compression drying is performed to obtain the rose bayberry extract.

3. A composition comprising Roselle as claimed in claim 2, wherein, The complex solvent is ethanol-ethyl acetate-fatty acid complex solvent in a volume ratio of 1-3:1:1-3.

4. A composition comprising Roselle as claimed in claim 2, wherein, The power of the plasma is 100-150 W, the time is 20-30 s, and the vacuum degree is 40-50 Pa.

5. A composition containing Roselle as claimed in claim 1, wherein, The coating protein is a mixture of corn alcohol-soluble protein and glycine in a mass ratio of 7-9:1-3, and then homogenization and emulsification are performed.

6. A composition comprising Roselle as claimed in claim 5, wherein, The pressure of the homogenization and emulsification is 30-40 MPa, and the temperature is 40-45℃.

7. A composition comprising Roselle as claimed in claim 1, wherein, The fermentation complex is a mixture of washed ginseng, raspberry and perilla in a mass ratio of 5-7:1-3:2, high pressure sterilization, then adding water to pulp in a solid-liquid ratio of 1:5 (g / mL), and then adding complex bacteria, and then fermenting at a temperature of 30-35℃ for 8-12h, and then inoculating an amount of 3%-5% of the total dry weight of the fermentation raw materials, and then sterilizing and cooling, and then reducing pressure compression drying to obtain the fermentation complex.

8. A composition comprising Roselle as claimed in claim 7, wherein, The complex bacteria are acetic acid bacteria, Saccharomyces cerevisiae and plant lactobacillus in a mass ratio of 1:1-3:1-3.

9. A composition comprising Roselle as claimed in claim 1, wherein, The auxiliary material is composed of oat beta-glucan, fish oil and chitosan in a mass ratio of 5:1-3:

1.

10. A process for the preparation of a roselle containing composition for the preparation of a roselle containing composition as claimed in any one of claims 1 to 9, wherein, The method comprises the following steps: Step 1: stirring and mixing rose bayberry extract, cocoa extract and coating protein at a temperature of 30-40℃ to obtain mixture A; Step 2: homogenizing the auxiliary material at a temperature of 30-40℃ for 20-30 min, and then mixing with the fermentation complex for 10-20 min to obtain mixture B; Step 3: stirring and mixing mixture A and mixture B, and then drying to obtain the rose bayberry composition.